Cerebrospinal Fluid Metabolomics of Pain in Patients with Spinal Muscle Atrophy

Pain Med. 2024 Dec 14:pnae129. doi: 10.1093/pm/pnae129. Online ahead of print.

Abby Pei-Ting Chiu^{1

2}, G A Nagana Gowda¹, Wentao Zhu¹, Lars Arendt-Nielsen^{3

4

5}, Daniel Raftery^{1

6}, Michele Curatolo^{1

2}

¹ Department of Anesthesiology and Pain Medicine, University of Washington, Seattle, WA, USA.
² Clinical, Learning, Evidence, And Research (CLEAR) Center, University of Washington, Seattle, WA, USA.
³ Center for Neuroplasticity and Pain (CNAP), SMI, Medical School, Aalborg University, Denmark.
⁴ Department of Gastroenterology & Hepatology, Mech-Sense, Clinical Institute, Aalborg University Hospital, Aalborg, Denmark.
⁵ Steno Diabetes Center North Denmark, Clinical Institute, Aalborg University Hospital, Aalborg, Denmark.
⁶ Division of Public Health Sciences, Fred Hutchinson Cancer Center, Seattle, WA, USA.

No abstract available

Keywords: cerebrospinal fluid; metabolomics; musculoskeletal pain; quantitative sensory testing; spinal muscle atrophy.